FDA product code DXP: Transducer, Vessel Occlusion

DXP is the FDA product code for transducer, vessel occlusion. It is a Class II device, regulated under 21 CFR 870.2890 and reviewed by the Cardiovascular panel. FDA has cleared 2 510(k) submissions under DXP, from 2 different applicants. The average 510(k) review took 58 days (median 58).

Classification

FieldValue
Device nameTransducer, Vessel Occlusion
Device classClass II
Regulation21 CFR 870.2890
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every DXP clearance

Top DXP applicants

ApplicantClearancesLatest
Ingress Technologies, Inc.11989-06-15
Frontier Products11981-10-02

Most recent DXP clearances

510(k)ApplicantDeviceDecision dateReview days
K891180Ingress Technologies, Inc.TRANSESOPHAGEAL ULTRASOUND ACCESSORIES KIT1989-06-15101
K812639Frontier ProductsUNICUFF1981-10-0216

Recalls for DXP devices

openFDA lists no recalls for product code DXP.

Frequently asked questions

What is FDA product code DXP?

DXP is the FDA product code for transducer, vessel occlusion. It is a Class II device, regulated under 21 CFR 870.2890 and reviewed by the Cardiovascular panel.

What device class is DXP?

Class II, regulation 21 CFR 870.2890. Typical premarket route: 510(k).

How long does a 510(k) take for product code DXP?

Across 2 cleared submissions the average was 58 days from receipt to decision (median 58).

Which companies have the most DXP clearances?

Ingress Technologies, Inc. (1); Frontier Products (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times